Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients
European Journal of Clinical Microbiology & Infectious Diseases1997Vol. 16(5), pp. 364–368
Citations Over TimeTop 12% of 1997 papers
Z. Erjavec, Gerhard Woolthuis, H. G. Vries-Hospers, Wim J. Sluiter, Simon Daenen, Ben de Pauw, M. R. Halie
Related Papers
- → Antileishmanial activity of nano-amphotericin B deoxycholate(2008)76 cited
- → Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy(2010)31 cited
- → Synergistic action of amphotericin B and rifampin against Rhizopus species(1987)63 cited
- → Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients(1991)57 cited
- → In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits(1997)7 cited